Laager左心耳封堵系统在非瓣膜性房颤患者中的安全性与有效性研究
本研究为前瞻性、多中心、非随机、单臂目标值法队列研究,纳入212例非瓣膜性房颤患者,评估Laager左心耳封堵系统的安全性与有效性。术后12个月187例患者完成经食管超声心动图检查,左心耳封堵成功率为96.8%(181/187),缺血性卒中发生率为0.5%(1/212)。结论提示Laager左心耳封堵器系统在非瓣膜性房颤患者卒中预防方面具有良好的安全性和有效性。
要点
- Laager左心耳封堵系统术后12个月封堵成功率为96.8%(181/187)。
- 缺血性卒中发生率为0.5%(1/212),安全性表现良好。
- 适用于CHA2DS2-VASc评分男性≥2分、女性≥3分且不适合长期华法林抗凝的患者。
核心结论
- Laager左心耳封堵器系统在非瓣膜性房颤患者的卒中预防方面具有良好的安全性和有效性。
研究设计与样本
- 本研究为前瞻性、多中心、非随机、单臂目标值法的队列研究。
- 2017年11月至2019年4月在全国12家中心连续纳入非瓣膜性房颤患者。
- 入选标准为CHA2DS2-VASc评分男性≥2分、女性≥3分,且不适合长期应用华法林抗凝治疗。
主要发现
- 共纳入212例非瓣膜性房颤患者,年龄(65.9±8.5)岁,女性86例(40.6%)。
- 210例(99.1%)患者实现术后即刻器械成功,2例患者术后即刻封堵器残余分流>3 mm。
- 术后12个月187例患者完成经食管超声心动图检查,左心耳封堵成功率为96.8%(181/187)。
- 缺血性卒中发生率为0.5%(1/212)。
关键数值与推荐
- 主要有效性终点为术后12个月经食管超声心动图提示残余分流≤3 mm。
- 主要安全终点为缺血性卒中的发生率。
- 术后12个月左心耳封堵成功率为96.8%(181/187)。
- 缺血性卒中发生率为0.5%(1/212)。
临床怎么用
- 对于CHA2DS2-VASc评分男性≥2分、女性≥3分且不适合长期华法林抗凝的非瓣膜性房颤患者,可考虑使用Laager左心耳封堵系统进行卒中预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the safety and efficacy of the Laager left atrial appendage occlusion system in stroke prevention in patients with atrial fibrillation. Methods: This was a prospective, multicenter, non-randomized, single-arm cohort study with prespecified performance goal. Patients with nonvalvular atrial fibrillation were enrolled at 12 centers nationwide from November 2017 to April 2019. All enrolled patients had CHA2DS2-VASc scores of ≥2 for males and ≥3 for females, and were not suitable for long-term warfarin anticoagulation therapy. All patients underwent left atrial appendage occlusion with the Laager occlusion system and were followed up. The primary efficacy endpoint was the rate of successful left atrial appendage occlusion, defined as a residual shunt ≤3 mm on transesophageal echocardiography at 12 months postoperatively. The primary safety endpoint was the incidence of ischemic stroke. Results: A total of 212 patients with nonvalvular atrial fibrillation were enrolled, with an age of (65.9±8.5) years, including 86 females (40.6%). Immediate procedural success was achieved in 210 patients (99.1%), and residual shunt >3 mm was observed in 2 patients post-procedure. At 12 months postoperatively, 187 patients completed transesophageal echocardiography (including 2 patients with residual shunt >3 mm post-procedure), and the success rate of left atrial appendage occlusion was 96.8% (181/187). The incidence of ischemic stroke was 0.5% (1/212). Conclusion: The Laager left atrial appendage occlusion system demonstrates favorable safety and efficacy for stroke prevention in patients with nonvalvular atrial fibrillation. 目的: 探讨Laager左心耳封堵系统在心房颤动(房颤)患者卒中预防中的安全性及有效性。 方法: 本研究为前瞻性、多中心、非随机、单臂目标值法的队列研究,2017年11月至2019年4月在全国12家中心连续纳入非瓣膜性房颤患者。所有入选患者CHA2DS2-VASc评分男性≥2分,女性≥3分,且不适合长期应用华法林抗凝治疗。所有患者接受Laager封堵系统左心耳封堵治疗并进行随访,主要有效性终点为左心耳封堵成功,定义为在术后12个月经食管超声心动图提示残余分流≤3 mm,主要安全终点为缺血性卒中。 结果: 共纳入212例非瓣膜性房颤患者,年龄(65.9±8.5)岁,女性86例(40.6%),210例(99.1%)患者实现术后即刻器械成功,2例患者术后即刻封堵器残余分流>3 mm。术后12个月187例患者完成经食管超声心动图检查(包含2例术后即刻封堵器残余分流>3 mm的患者),左心耳封堵成功率为96.8%(181/187),缺血性卒中发生率为0.5%(1/212)。 结论: Laager左心耳封堵器系统在非瓣膜性房颤患者的卒中预防方面具有良好的安全性和有效性。.
引用
- Ding, Jiang, Cai, et al. [Safety and efficacy of Laager left atrial appendage occlusion system in patients with nonvalvular atrial fibrillation: a prospective, multicenter clinical study]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 42595523. doi:10.3760/cma.j.cn112148-20260306-00144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。